Recombinant broad spectrum vaccine (Osivax)

N/A

Report date: 2024/12/06 10:41:40

Base Information

Drug NameRecombinant broad spectrum vaccine (Osivax)
Drug Alias NameOVX-836
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsVaccine-Preventable DiseasesInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumAustraliaGermany +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOsivax Sas
China Registration ClassN/A

Develop Information

Active CompaniesOsivax SasKM Biologics Co Ltd
Inactive CompaniesN/A
Active IndicationsVaccine-Preventable DiseasesInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A